» Articles » PMID: 39396946

The Impact of an Open-label Design on Human Amniotic Membranes Vs. Silver Sulfadiazine Dressings for Second-degree Burns: a Randomized Controlled Clinical Trial

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2024 Oct 13
PMID 39396946
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Burn wounds require optimal medical management due to associated psycho-emotional and socioeconomic impacts and severe pain. The use of synthetic and biological dressings improves healing and reduces burn wound complications. The present study aimed to compare the outcomes of using human amniotic membrane (hAM) dressings and conventional silver sulfadiazine (SSDZ) ointment dressings in the management of second-degree burn wounds.

Methods: Fifty patients who participated in this clinical trial were divided into two groups via simple randomization. All the enrolled patients, who had burnt in the last 24 h, had thermal damage mechanisms and were suffering from less than 20% second-degree heat-burn wounds on the skin surface. The target group (n = 25) was treated with hAM, and the control group (n = 25) was treated with SSDZ ointment. The researcher-designed checklist was used to determine the clinical performance in the follow-up assessments on days 7, 14, and 30.

Results: No significant differences were detected in terms of sex, age, or percentage of burn wounds (p > 0.05). Wound epithelialization at days 7, 14, and 30, scar formation, wound pigmentation, pain severity, analgesia requirements, and hospital stay length (on day 30) were significantly lower in the target group (treated with hAM) than in the control group (treated with SSDZ ointment) (p < 0.05). However, treatment costs in the target group ($170) were significantly higher than those in the control group ($71) (p < 0.001).

Conclusion: Despite its higher cost, hAM, as a technology-based therapy dressing, demonstrates superiority over SSDZ ointment in terms of wound healing and pain management.

References
1.
Morgan M, Deuis J, Frosig-Jorgensen M, Lewis R, Cabot P, Gray P . Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment. Pain Med. 2017; 19(4):708-734. DOI: 10.1093/pm/pnx228. View

2.
Resch A, Staud C, Radtke C . Nanocellulose-based wound dressing for conservative wound management in children with second-degree burns. Int Wound J. 2021; 18(4):478-486. PMC: 8273580. DOI: 10.1111/iwj.13548. View

3.
Leal-Marin S, Kern T, Hofmann N, Pogozhykh O, Framme C, Borgel M . Human Amniotic Membrane: A review on tissue engineering, application, and storage. J Biomed Mater Res B Appl Biomater. 2020; 109(8):1198-1215. DOI: 10.1002/jbm.b.34782. View

4.
Hawker G, Mian S, Kendzerska T, French M . Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain.... Arthritis Care Res (Hoboken). 2012; 63 Suppl 11:S240-52. DOI: 10.1002/acr.20543. View

5.
Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I . Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res. 2010; 106(10):1613-23. DOI: 10.1161/CIRCRESAHA.109.205260. View